Foamix Pharmaceuticals Ltd. (FOMX) Stock: Great Point Partners Boosts its Stake to 7.57%

Page 2 of 10

Page 2 of 10 – SEC Filing
CUSIP
No. M46135105
13G Page
2 of 9 Pages
1.

NAMES OF REPORTING PERSONS

Great Point Partners, LLC

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES
ONLY):

37-1475292

2. CHECK THE APPROPRIATE BOX IF A MEMBER
OF A GROUP
(a) o
(b) o
3. SEC USE ONLY
4.

CITIZENSHIP OR PLACE OF ORGANIZATION

USA

NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
5. SOLE VOTING POWER
0
6. SHARED VOTING POWER
2,769,425
7. SOLE DISPOSITIVE POWER
0
8. SHARED DISPOSITIVE POWER
2,769,425
9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON

2,769,425

10. CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES
(See Instructions)
o
11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

7.57%1

12.

TYPE OF REPORTING PERSON (See Instructions)

IA

1 Based on a total of 36,599,397 shares outstanding, as reported
in the Issuer’s Form 424B5 Prospectus filed with the SEC on September 27, 2016.

Follow Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX)

Page 2 of 10